Related Experiment Video
Updated: Jul 31, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Withaferin A for COVID-19: a Network Pharmacology Approach
Ashasmita S Mishra1, Bhuvaneswari Varadarajan1, Srayaa Sathish1
1Department of Biotechnology, Rajalakshmi Engineering College, Thandalam, Chennai, 602105, India.
Withaferin A shows potential as a COVID-19 treatment by targeting key proteins involved in thrombosis and immune response. This natural compound may help manage cytokine storms and reduce COVID-19 complications.
Area of Science:
- Pharmacology
- Computational Biology
- Immunology
Background:
- COVID-19 presents significant treatment challenges due to its wide-ranging physiological impacts, including immunological injury and multi-organ dysfunction.
- Existing therapeutic options for COVID-19 are limited, necessitating novel approaches like systems pharmacology.
Purpose of the Study:
- To investigate Withaferin A as a potential system pharmacophore for combating COVID-19 and its associated complications.
- To identify key molecular targets of Withaferin A relevant to COVID-19 pathophysiology.
Main Methods:
- Utilized molecular docking (AutoDock Vina) to assess binding affinities.
- Employed bioinformatics tools including PharmMapper, STRING database, and PANTHER Pathway analysis.
- Performed text mining to identify associations between Withaferin A and relevant biological pathways.
Main Results:
- Withaferin A demonstrated significant binding affinity to P2Y12 receptor, vitamin D-binding protein, and annexin A5, suggesting anti-thrombotic potential.
- Protein-protein interaction analysis highlighted Withaferin A's role in the innate immune system and T cell activation.
- Text mining revealed a link between Withaferin A and STAT3, indicating potential for modulating cytokine storms.
Conclusions:
- Withaferin A is proposed as a system pharmacophore for COVID-19 drug development.
- Identified vitamin D-binding protein and STAT3 as key targets for Withaferin A's therapeutic effects against COVID-19 complications.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
12:34Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
Published on: January 12, 2024
Related Concept Videos
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Discovery: Overview
Factors Affecting Drug Response: Overview
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Biopharmaceutics and Pharmacokinetics: Overview